Brighten Optix Corporation (TPEX:6747)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
135.00
+1.00 (0.75%)
Apr 24, 2025, 1:24 PM CST
-13.75%
Market Cap 3.64B
Revenue (ttm) 766.93M
Net Income (ttm) 149.79M
Shares Out 27.20M
EPS (ttm) 5.49
PE Ratio 24.41
Forward PE n/a
Dividend 9.19 (6.86%)
Ex-Dividend Date Apr 17, 2025
Volume 9,981
Average Volume 17,000
Open 136.00
Previous Close 134.00
Day's Range 135.00 - 136.50
52-Week Range 124.00 - 164.52
Beta 0.14
RSI 41.25
Earnings Date May 15, 2025

About Brighten Optix

Brighten Optix Corporation researches, develops, manufactures, and sells contact lenses in Taiwan and internationally. The company offers orthokeratology, a non-invasive and reversible method of vision correction by using a hard contact lens to alter the shape of the front surface of the cornea; gas permeable lenses for single vison, multifocal, and irregular cornea and keratoconus correction, under the HiClear, So2clear, Menicon, Duette, ROSE K, Ampleye, MAXIM 3D, AND ULTRAHEALTH brand name; and soft contact lenses under the iDealsoft, Briomoi... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 1965
Country Taiwan
Stock Exchange Taipei Exchange
Ticker Symbol 6747
Full Company Profile

Financial Performance

In 2024, Brighten Optix's revenue was 766.93 million, an increase of 2.63% compared to the previous year's 747.30 million. Earnings were 149.79 million, a decrease of -24.82%.

Financial Statements

News

There is no news available yet.